News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cadence Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2012 Financial Results on March 7, 2013


3/1/2013 9:46:44 AM

SAN DIEGO, Feb. 28, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that it will release its fourth quarter and full year ended December 31, 2012 financial results on Thursday, March 7, 2013.

Cadence management will host a conference call and live webcast to discuss the financial results on Thursday, March 7, 2013 at 5:30 am Pacific Time (8:30 am Eastern Time). Interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international). To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page. A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the "Investors" page of www.cadencepharm.com, under "Events and Presentations."

Contacts:

William R. LaRue


SVP & Chief Financial Officer


Cadence Pharmaceuticals, Inc.


858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES